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INTRODUCTION
Human herpesvirus-6 (HHV-6) is a ubiquitous betaherpes-
virus with lymphotropic and neurotropic potential existing
in variants A and B (Hall et al., 1998; Santoro et al., 1999),
which were re-classified as separate species (HHV-6A and
HHV-6B) in 2012 by the International Committee on Tax-
onomy of Viruses, based on the different bio characteristics
regarding cell tropism and pathological implications
(Ablashi et al., 2014). Although the primary targets for
HHV-6 replication, both in vitro and in vivo, are CD4+ and
CD8+ T lymphocytes (Lusso, 2006), some studies found
HHV-6 sequences in different solid organs, including in the
thyroid gland (Chen and Hundal, 2006; Alvarez-Lafuente et
al., 2008). HHV-6 has immunomodulating properties,
which may operate in several autoimmune disorders,
including autoimmune hemolytic anemia/neutropenia (Yaga-
saki et al., 2011), autoimmune acute hepatitis (Grima et al.,
2008), and multiple sclerosis (Chapenko, 2003; Tejada-Si-
mon et al., 2003; Nora-Krukle et al., 2011). Although the po-
tential mechanism of autoimmune pathogenesis by HHV-6
remains unknown, molecular mimicry may play a role in the
initiation of self-reactive immune responses (Dagna et al.,
2013). Recent studies show possible involvement of
herpesviruses in development of autoimmune thyroid disease
(Thomas et al., 2008; Caselli et al., 2012).
The aim of this study was to determine loads of HHV-6 in
thyroid gland tissue in comparison to those in peripheral
blood of patients with autoimmune thyroiditis.
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Human herpesvirus-6 (HHV-6) is a ubiquitous betaherpesvirus with immunomodulating properties
that have been suggested to play an important role in the development of several autoimmune
disorders. Although the primary targets for HHV-6 replication, both in vitro and in vivo, are CD4+
and CD8+ T lymphocytes, some studies have reported the presence of HHV-6 sequences in dif-
ferent solid organs, including in the thyroid gland, showing possible involvement of this
herpesvirus in development of autoimmune thyroid disease. The aim of this study was to deter-
mine loads of HHV-6 in thyroid gland tissue in comparison to those in peripheral blood of patients
with autoimmune thyroiditis. Seven patients [women mean age 45 (28–65)] with histologically
confirmed autoimmune thyroiditis were enrolled in this study. Fluorescence-activated cell sorting
was used to distinguish and sort lymphocyte populations from peripheral blood mononuclear cells
of patients. HHV-6 load was determined by real-time PCR for peripheral blood and thyroid gland
tissue samples. Additionally, all results from molecular analyses were compared with histological
results obtained by light microscopy. Viral load was detected only in one (46 viral copies/
1×106cells) blood sample; others were under the detection limit of the used kit. However, in all
HHV-6 positive tissue samples viral load was detected in the range of 132–1620 viral copies/106
cells. Substantial HHV-6 load in lymphocyte subpopulations was detected in two of seven pa-
tients. HHV-6 load was detected in NK and CD95+ cells of two patients. The obtained results
show that thyroid gland cells (tyrocytes) act as target cells for HHV-6.
Key words: HHV-6, autoimmune thyroiditis, cell sorting, light microscopy.
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MATERIALS AND METHODS
Seven patients (women mean age 45, range 28 to 65) with
histologically confirmed autoimmune thyroiditis were en-
rolled in this study. Samples from patients were tested for
the presence of auto-antibodies to thyroid peroxidase
(TPO), thyroglobulin (TG) and thyroid stimulant hormone
receptor (TSH).
Patients had the following clinical diagnoses: Struma no-
dosa III thyreotoxicum (n = 3) and Struma nodosa III euthy-
reocum (n = 4). Surgical treatment Thyreoidectomia totalis
was applied to all patients.
Light microscopy. Tissue samples from thyroid glands of
autoimmune thyroiditis (AIT) patients were fixed in 4%
glutaraldehyde in phosphate buffer for 24 h and post-fixed
in osmium tetraoxide for 24 h. After dehydration in acetone
(70–100%), the specimens were processed in acetone-resin
Durcupan 1 (without accelerator) mixture for 24 h at 50 °C
and embedded in resin Durcupan 2 (with accelerator added).
Semi-thin (thick) sections (0.5 um) were cut using a ultra-
microtome Reichert-Jung, Austria, collected in a metal
loop, transferred to a drop of distilled water on glass slides,
dried at 50 °C for 10 min and stained with centrifuged
toluidine blue at high temperature. Slides were rinsed with
distilled water and dried at room temperature. The observa-
tions were carried under immersion by light microscope
(Leica DM 500B, Wetzlar, Germany) and images were re-
corded using a connected digital camera.
The stained materials were used for general morphological
analysis to determine the areas of interest for further TEM
(transmission electron microscope) observation. All chemi-
cals were purchased from Sigma Aldrich Chemie GmbH,
Germany.
HHV-6 genomic sequence detection. Nested polymerase
chain reaction (nPCR) was used to detect HHV-6 genomic
sequences in DNA isolated from whole blood and thyroid
tissue, in accordance with Secchiero et al. (1995). A posi-
tive control (HHV-6 genomic DNA; Advanced Biotech-
nologies Inc, Columbia, MD, USA) and a negative control
(DNA obtained from practically healthy HHV-6 negative
blood donors and a water control) were included in each ex-
periment.
The HHV-6 load in whole blood and tissue samples from
patients with HHV-6 persistent infection (DNA sequence in
peripheral blood DNA) was determined using a HHV-6
Real-TM Quant Real-TM kit (Sacace, Italy) and Applied
Biosystems 7500 Real-time PCR System (Applied Biosys-
tems, Carlsbad, CA, USA), in accordance with the manu-
facturer’s recommendations. Collected data were processed
and analyzed with the specialised software ABI 7500 sys-
tem to calculate viral load as viral copies/106 cells.
FACS sorting. BD FACSAria II flow cytometer (USA) and
BD FACSDiva software were used for sorting and analysis
of peripheral blood mononuclear cells (PBMC). Commer-
cial monoclonal antibodies conjugated with flourochromes
(anti- CD3-FITC, CD4-PerCP-Cy7, CD8-PE, CD16-V450,
CD19-APC, CD45-V500, CD56-V450 and CD95-PerCP-
Cy 5.5) were used to distinguish and sort lymphocyte popu-
lations.
All procedures were performed with standard BD protocols
for staining and sorting PBMC’s. The study was approved
by the Ethics Committee of Rîga Stradiòð University, and
written consent was obtained from all patients.
RESULTS
Light microscopy. Microscopic examination of paren-
chyma units of the examined thyroid glands showed differ-
ent stages of follicular damage and degeneration, expressed
in alteration of follicular shape and cell appearance, de-
creased intensity of colloid staining, extensive lymphoid
cell infiltration, coalescence of adjacent follicles and atro-
phy, and slight fibrosis of the interstitial tissues. In cases di-
agnosed as macrofollicular colloid struma, thyroid follicles
consisted mainly of more or less flattened thyrocytes (fol-
licular epithelium), where some cells had enlarged or over-
lapping nuclei and a central mass of colloid with tinctorial
variations (Fig 1a, b; Fig. 2). In cases of microfollicular col-
loid struma and follicular adenomas (Fig. 3), we observed
small and fewer thyroid follcules with cubical cells in ring-
like position. The examined materials also showed morpho-
logical features characteristic of cell death of thyrocytes,
such as: light-colored and vacuolated cells with polymor-
phic, fragmented or pyknotic nuclei and focal necroses in
some specimens (Fig. 1a, b, Fig. 3). Small and fewer large
and lighter staining parafollicular cells (C cells) were seen
near the basement lamina in the confines of the residual fol-
licles, excluded from the lumen by follicular epithelium.
Lymphoid cell migration (predominantly lymphocytes and
plasma cells) was observed as in the follicles – around the
parenchyma cells and in the colloid (Fig. 2) as well in the
interstitium of the examined glands of AIT patients.
Lesions varied from initial alterations of parenchyma to fi-
brosis progress around the residual follicles and layers of
the loose connective tissue, containing capillary network
(Fig. 1b, Fig. 3).
HHV-6 load in peripheral blood and thyroid tissue sam-
ples. Using real-time polymerase chain reaction (RT-PCR),
HHV-6 load was determined whole blood and thyroid gland
tissue of patients. In patient blood the viral load was de-
tected only in one (46 viral copies/1 × 106 cells) sample,
others were under the detection limit of the used kit, while
in all HHV-6 positive tissue samples viral load was detected
within the range 132–1620 copies/106 cells. However, in all
patients enrolled in this study (7/7; 100%), the HHV-6 ge-
nomic sequence in tissue and blood DNA samples was de-
tected using nPCR.
FACS sorting of lymphocytes’ subpopulations. The dif-
ference in frequency of the HHV-6 genomic sequence in
thyroid tissue and peripheral blood samples was studied by
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sorting main lymphocytes subpopulations (CD4+, CD8+,
CD16+, CD19+ and CD95+) from PBMC of 7 patients with
AIT.
DNA from the main lymphocyte subpopulations was also
examined by RT-PCR. Substantial HHV-6 load in lympho-
cyte subpopulations was detected in two of seven patients.
In the first patient, who was positive for the presence of the
HHV-6 genomic sequence in whole blood and thyroid gland
tissue DNA using nPCR, HHV-6 load was detected in NK
and CD95+ cells (24 and 100 viral copies/1 × 106 cells, re-
spectively). In this patient also a lower HHV-6 load was de-
tected in whole blood (46 copies/1x106 cells) comparing to
tissue, where the HHV-6 load was 355 copies/1x106 cells
(Fig. 4). In the second patient, who was nPCR positive for
the presence of HHV-6 genomic sequence only in tissue
DNA of the thyroid gland, the HHV-6 load was detected
only in CD95+ cells — 40 copies/1 × 106 cells (Fig. 4). In
the other five patients, HHV-6 load was not detected in
lymphocytes’ subpopulations and whole blood samples be-
cause they were under detection limit of the used kit (< 5
copies per reaction).
DISCUSSION
Thyroid gland, as a highly reactive organ, regulating growth
and normal metabolism, may be affected by a variety of di-
rect or indirect physical, chemical or biological agents.
Since effects on the thyroid may be subtle or related to age
and environmental conditions, it is necessary to provide a
wide range of diagnostic techniques targeting proper medi-
cal decisions and excluding cancer formation stages.
162 Proc. Latvian Acad. Sci., Section B, Vol. 70 (2016), No. 4.
Fig. 1. Different stages of follicular damage and lymphoid infiltration in thyroid glands of patients diagnosed with autoimmune thyroiditis. Dilatation and
loss of normal follicular shape, flattened epithelium and decreased intensity of colloid staining in some of the follicles, fibrosis of loose conective tissue,
macrofollicular colloid struma (a); coalescence of adjacent follicles, focal necroses and fibrotic bands in the intersticial connective tissue (b); F-follicular
cells, Pf- parafollicular cells, L-lymphoid cells, Ct- fibrotic bands in connective tissue, Fc-fibrocyte, C-colloid, Bv-blood vessels; semi-thin sections (0.5 um),
immersion, light microscope Leica DM 5000B, ×100, Westzlar, Germany.
a b
Fig. 2. Thyroid gland of patient diagnosed with autoimmune thyroiditis
and macrofollicular colloid struma: thyroid follicles with flattened
follicular epithelium and shrunk parenchymal cells with pycnotic or frag-
mented nuclei. Lymphocyte migration into the follicular colloid;
F-follicular cells, L-lymphoid cells; semi-thin sections (0.5 um), immer-
sion, light microscope Leica DM 5000B, ×100, Westzlar, Germany.
Fig. 3. Thyroid gland of patient diagnosed with autoimmune thyroiditis
and follicular adenoma: atrophic and small follicles with abundance of
cuboidal to low columnar follicular cells and lymphoid cells, reduction of
the colloid, focal necroses and fibrotic bands in the intersticium;
F-follicular cells, L-lymphoid cells; semi-thin sections (0.5 um), immer-
sion, light microscope Leica DM 5000B, ×100, Westzlar, Germany.
Light microscopic examination showed a lymphocytic infil-
tration as a histological finding, which needs to be sup-
ported by high serum titers of anti-thyroid autoantibodies to
confirm autoimmune thyroiditis.
Dilatation and loss of normal follicular shape, flattened
follicular epithelium are characteristic of hypofunction of
the thyroid gland associated with the development of the
condition macrofollicular struma nodosa, which could be
caused not only by simple lack of iodine, but also by auto-
immune problems. We observed microfollicular architec-
ture and cuboidal epithelial cells in specimens of patients
diagnosed with microfollicular colloid struma and follicular
adenoma. McHenry and Phitayakorn (2011) reported that
most patients with a follicular adenoma were clinically and
biochemically euthyroid and approximately 1% of follicular
adenomas — “toxic adenomas” showed hyperthyroidism. In
our study Struma nodosa III thyreotoxicum was found in
three and Struma nodosa III euthyreocum in four of the
cases, and two patients had developed follicular adenomas.
In the development of benign tumors and progression to
cancer of thyroid gland, factors such as gene mutations,
gene rearrangement and oncogene activation are suspected
(Nikiforova et al., 2003; McHenry and Phitayakorn, 2011).
Also, factors including cell receptor transformation are sus-
pected as triggers initiating autoimmune processes affecting
the thyroid gland. Viral infections, in particular HHV6 with
its immunomodulating properties, could be a facilitator or
have direct influence on development of autoimmune pro-
cesses in the thyroid gland (Dagna et al., 2013).
This study was designed to evaluate the relationship of the
mentioned conditions to HHV-6 infection.
As HHV-6 is a lypmhotrophic virus, we expected to see its
dominance in whole blood samples and especially in CD4
and CD8 T-lymphocytes populations, which was not sup-
ported by molecular findings. HHV-6 load was detected
only in one patient’s whole blood sample but others were
under detection limit of the kit (< 5 viral copies per reac-
tion). Also, none of the CD4 and CD8 T-lymphocytes sub-
populations of patients showed HHV-6 load, and a very low
HHV-6 load was found only in CD95+ cells (100 and 40
copies/106 cells) of two patients’ and in NK cells (24 cop-
ies/106 cells) of one patient
A low HHV-6 load in peripheral blood immunocompetent
cells and in overall blood samples, in comparison to thyroid
tissue, demonstrates that the persistency site for HHV-6
could be the thyroid gland. In addition, the provided light
microscopic examination suggested signs of impaired thy-
roid follicular structure and particularly, thyrocytes, which
supports the idea that peripheral blood lymphocytes are tar-
get cells for HHV-6 persistency in patients with autoim-
mune thyroiditis.
In addition, presence of the HHV-6 genomic sequence in
some immunocompetent cell populations indicates that the
virus can infect thyroid gland during inflammation in the
autoimmune process. In that scenario, HHV-6 more likely
acts as a facilitator, but more detailed investigation with a
larger patient group is required.
The presented results logically lead to further investiga-
tions, including electron microscopic observation to detect
viral particles or assembled viruses in thyroid gland tissue.
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TIREOCÎTI KÂ CILVÇKA HERPESVÎRUSA-6 INFEKCIJAS MÇRÍÐÛNAS PACIENTIEM AR AUTOIMÛNO TIREOIDÎTU
Cilvçka herpesvîruss seði (HHV-6) ir izplatîts imûnmodulçjoðs betaherpesvîruss, kas tiek asociçts ar vairâku autoimûno slimîbu attîstîbu.
HHV-6 replicçjas CD4+ un CD8+ ðûnâs in vitro un in vivo, taèu ir pçtîjumi, kur HHV-6 genoma sekvenci atrod ne tikai T limfocîtos, bet arî
daþâdu orgânu audos, tai skaitâ vairogdziedziera audos. Tâdçï ðie pçtîjumi liecina par herpesvîrusa iespçjamo iesaisti autoimûno
vairogdziedzera slimîbu attîstîbâ. Ðî pçtîjuma mçríis bija noskaidrot HHV-6 atðíirîgâs klâtbûtnes nozîmîgumu audos un asinîs pacientiem
ar autoimûno tireoidîtu. Ðajâ pçtîjumâ tika iekïauti septiòi pacienti (sievietes ar vidçjo vecumu 45 gadi (28–65)), kuriem histoloìiski bija
apstiprinâts autoimûns tireoidîts. Fluorescences aktivizçta ðûnu sortçðana (FACS) tika izmantota, lai no pacientu perifçro asiòu
mononukleârajâm ðûnâm atðíirtu un sortçtu limfocîtu populâcijas. Tika salîdzinâta HHV-6 slodze vairogdziedzera audu un perifçro asiòu
paraugos. Turklât visi molekulâro pçtîjumu rezultâti tika salîdzinâti un analizçti ar gaismas mikroskopijas rezultâtiem. HHV-6 slodze tika
konstatçta viena pacienta asins paraugâ (46 vîrusa kopijas/1 × 106 ðûnu) un pârçjo pacientu asins paraugos slodze bija zemâka par
detektçjamo robeþu, tikmçr HHV-6 slodze vairogdziedzera audu paraugos tika konstatçta visos paraugos (132 – 1620 vîrusa kopijas/1 × 106
ðûnu). Diviem no septiòiem pacientiem tika konstatçta bûtiska HHV-6 slodze limfocîtu subpopulâcijâs. HHV-6 slodze tika konstatçta NK
un CD95 + ðûnâs diviem pacientiem.
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